Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Bradley

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Cancer Genetics|January 24, 2021
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphomaSantosh Khanal, Todd Bradley
JAMA|June 24, 2015
Broadly Neutralizing Antibodies and the Development of VaccinesBarton F Haynes, Todd Bradley
Pediatric Research|January 19, 2024
Correction: Triggered - does maternal COVID-19 program an exaggerated immune response in neonates?Todd Bradley, Megan Tucker, Venkatesh Sampath
Pediatric Research|January 3, 2024
Triggered - does maternal COVID-19 program an exaggerated immune response in neonates?Todd Bradley, Megan Tucker, Venkatesh Sampath
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccineTodd Bradley, Elin Grundberg, Rangaraj Selvarangan
Frontiers in Cellular and Infection Microbiology|June 9, 2020
Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune ResponseStephen Pierce, Eric S Geanes, Todd Bradley
RNA (New York, N.Y.)|November 22, 2014
SR proteins control a complex network of RNA-processing eventsTodd Bradley, Malcolm E Cook, Marco Blanchette
Research Square|October 16, 2023
Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severityTodd Bradley, Eric Geanes, Rebecca McLennan, et al.
Communications Medicine|March 16, 2024
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severityEric S Geanes, Rebecca McLennan, Cas LeMaster, et al.
Clinical and Translational Science|December 6, 2021
Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?Jennifer Halma, Stephen Pierce, Rebecca McLennan, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Cancer Genetics|January 24, 2021
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphomaSantosh Khanal, Todd Bradley
JAMA|June 24, 2015
Broadly Neutralizing Antibodies and the Development of VaccinesBarton F Haynes, Todd Bradley
Pediatric Research|January 19, 2024
Correction: Triggered - does maternal COVID-19 program an exaggerated immune response in neonates?Todd Bradley, Megan Tucker, Venkatesh Sampath
Pediatric Research|January 3, 2024
Triggered - does maternal COVID-19 program an exaggerated immune response in neonates?Todd Bradley, Megan Tucker, Venkatesh Sampath
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccineTodd Bradley, Elin Grundberg, Rangaraj Selvarangan
Frontiers in Cellular and Infection Microbiology|June 9, 2020
Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune ResponseStephen Pierce, Eric S Geanes, Todd Bradley
RNA (New York, N.Y.)|November 22, 2014
SR proteins control a complex network of RNA-processing eventsTodd Bradley, Malcolm E Cook, Marco Blanchette
Research Square|October 16, 2023
Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severityTodd Bradley, Eric Geanes, Rebecca McLennan, et al.
Communications Medicine|March 16, 2024
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severityEric S Geanes, Rebecca McLennan, Cas LeMaster, et al.
Clinical and Translational Science|December 6, 2021
Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?Jennifer Halma, Stephen Pierce, Rebecca McLennan, et al.
Pageof 7